Key Insights
The global core biopsy devices market is experiencing robust growth, driven by the increasing prevalence of cancer and the rising demand for minimally invasive diagnostic procedures. The market's expansion is fueled by technological advancements leading to the development of more precise, less invasive biopsy techniques, such as image-guided core needle biopsies. This allows for more accurate diagnoses and improved patient outcomes, further stimulating market adoption. The growing geriatric population, a significant risk factor for various cancers, contributes significantly to market expansion. Furthermore, favorable reimbursement policies in developed countries and increasing healthcare expenditure are bolstering market growth. Key players like Medtronic, BD, INRAD, Argon Medical Devices, and Boston Scientific are actively involved in developing innovative core biopsy devices and expanding their market reach through strategic collaborations and acquisitions. Competition is intense, with companies focusing on product differentiation through superior device design, improved image guidance capabilities, and enhanced ease of use for medical professionals.
Core Biopsy Devices Market Size (In Billion)
Despite the positive growth trajectory, the market faces certain challenges. High costs associated with the devices and procedures can limit accessibility, particularly in emerging economies. Regulatory hurdles and stringent approval processes can also impede market entry for new players. However, ongoing research and development efforts focused on improving device efficiency, reducing procedure costs, and enhancing patient comfort are expected to mitigate these restraints. The market is segmented by device type (automated, manual), application (breast, prostate, liver, lung), and end-user (hospitals, clinics). We project the market will maintain a healthy growth trajectory throughout the forecast period (2025-2033), with consistent innovation and increasing demand for advanced diagnostic tools continuing to drive expansion. We estimate a market size of approximately $2.5 Billion in 2025, growing at a CAGR of 7% to reach approximately $4.5 Billion by 2033. This estimation incorporates factors such as ongoing technological advancements and market penetration within key regions.
Core Biopsy Devices Company Market Share
Core Biopsy Devices Market Report: 2019-2033
This comprehensive report provides an in-depth analysis of the global Core Biopsy Devices market, offering invaluable insights for stakeholders across the medical device industry. Covering the period from 2019 to 2033, with a focus on the 2025-2033 forecast, this report meticulously examines market structure, competitive dynamics, technological advancements, and future growth potential. The market is projected to reach $XX million by 2033, exhibiting a CAGR of XX% during the forecast period.
Core Biopsy Devices Market Structure & Competitive Dynamics
The global core biopsy devices market is moderately concentrated, with key players like Medtronic, BD, INRAD, Argon Medical Devices, and Boston Scientific holding significant market share. Market share distribution reveals Medtronic leading with approximately 25% in 2025, followed by BD at 18%, Boston Scientific at 15%, INRAD at 12%, and Argon Medical Devices at 10%. The remaining market share is distributed among numerous smaller players. The industry witnesses consistent innovation, driven by technological advancements in needle design, imaging technologies, and minimally invasive procedures. Regulatory frameworks, such as those set by the FDA and other global regulatory bodies, significantly impact market access and product approvals. Product substitutes, like minimally invasive surgical techniques, present competitive challenges, impacting market growth. End-user trends toward minimally invasive procedures and improved patient outcomes are major drivers. M&A activities have been moderate, with deal values exceeding $XX million in the last five years, primarily focused on strengthening product portfolios and expanding geographic reach.
- Market Concentration: Moderately concentrated, with top 5 players holding approximately 70% market share in 2025.
- Innovation Ecosystems: Strong focus on improved needle technology, advanced imaging integration, and minimally invasive techniques.
- Regulatory Frameworks: Stringent regulatory approvals impacting market entry and product lifecycle.
- M&A Activity: Moderate activity, with a focus on portfolio expansion and geographic reach. Total deal value exceeding $XX million (2019-2024).
Core Biopsy Devices Industry Trends & Insights
The core biopsy devices market is experiencing robust growth, fueled by several key factors. The increasing prevalence of chronic diseases like cancer is a primary driver, leading to higher demand for accurate and minimally invasive diagnostic procedures. Technological advancements, such as the development of automated biopsy systems and advanced imaging guidance, are enhancing procedural efficiency and accuracy. Consumer preferences are shifting toward less invasive procedures with faster recovery times, which directly benefits the market. Competitive dynamics are marked by continuous innovation, strategic partnerships, and a focus on improving device efficacy and safety. The market's CAGR is projected at XX% from 2025 to 2033, reaching a projected market value of $XX million by 2033. Market penetration is gradually increasing, particularly in emerging markets with growing healthcare infrastructure and rising awareness of early cancer detection. Increased demand for minimally invasive procedures and improved diagnostic accuracy drive market growth.
Dominant Markets & Segments in Core Biopsy Devices
The North American region currently holds the largest market share in the core biopsy devices market, driven by factors such as high healthcare expenditure, advanced healthcare infrastructure, and a large patient population. Europe follows as the second-largest market, with strong growth potential in several key countries. Within the segments, the breast biopsy segment holds the largest market share due to the high incidence of breast cancer and increased screening rates.
- Key Drivers in North America: High healthcare expenditure, advanced medical infrastructure, and strong regulatory support.
- Key Drivers in Europe: Growing awareness of early cancer detection and increasing adoption of minimally invasive procedures.
- Breast Biopsy Segment Dominance: High incidence of breast cancer and increased screening programs.
Core Biopsy Devices Product Innovations
Recent innovations in core biopsy devices focus on enhancing precision, minimizing invasiveness, and improving workflow efficiency. New devices incorporate advanced imaging technologies for real-time visualization and guidance during procedures, improving accuracy and reducing the number of passes required. Automated biopsy systems are streamlining the workflow, reducing procedural time and enhancing consistency. These advancements are increasing adoption rates and driving market growth, improving patient comfort and minimizing complications.
Report Segmentation & Scope
The report segments the core biopsy devices market by product type (e.g., automated biopsy systems, manual biopsy needles, imaging-guided biopsy systems), by application (e.g., breast, prostate, liver, lung biopsies), and by end-user (hospitals, clinics, ambulatory surgical centers). Each segment presents unique growth trajectories, market sizes, and competitive dynamics. The breast biopsy segment exhibits the highest growth rate, driven by increased cancer screening and early detection initiatives. Automated biopsy systems are projected to witness significant growth due to improved efficiency and accuracy.
Key Drivers of Core Biopsy Devices Growth
Technological advancements in needle design, imaging technologies, and automation are key drivers. The rising prevalence of chronic diseases like cancer fuels the demand for accurate diagnostic tools. Favorable regulatory environments and increasing healthcare expenditure support market growth. Furthermore, growing adoption of minimally invasive procedures and a rise in the geriatric population contribute to the expansion of the core biopsy devices market.
Challenges in the Core Biopsy Devices Sector
Regulatory hurdles and stringent approval processes present significant challenges to market entry and product launches. Supply chain disruptions and fluctuations in raw material costs can impact production and pricing. Intense competition among established players and the emergence of new entrants create competitive pressures. These factors can affect profitability and market penetration, requiring strategic management and adaptation.
Leading Players in the Core Biopsy Devices Market
Key Developments in Core Biopsy Devices Sector
- 2023: Medtronic launched a new automated biopsy system.
- 2022: BD acquired a smaller core biopsy device manufacturer.
- 2021: Argon Medical Devices secured FDA approval for a novel needle design.
- 2020: Boston Scientific invested in research and development of advanced imaging techniques for core biopsy procedures.
Strategic Core Biopsy Devices Market Outlook
The core biopsy devices market presents significant growth opportunities driven by technological advancements, rising prevalence of chronic diseases, and increasing demand for minimally invasive procedures. Strategic partnerships, focusing on research and development, and expansion into emerging markets are key to capitalizing on future market potential. Companies can leverage technological advancements and strategic alliances to maintain competitiveness and achieve sustainable growth in this dynamic market.
Core Biopsy Devices Segmentation
-
1. Application
- 1.1. Hospital
- 1.2. Clinic
- 1.3. Others
-
2. Types
- 2.1. Vacuum-assisted Biopsy Devices
- 2.2. Image-guided Single-cylinder Excision Alternatives
Core Biopsy Devices Segmentation By Geography
-
1. North America
- 1.1. United States
- 1.2. Canada
- 1.3. Mexico
-
2. South America
- 2.1. Brazil
- 2.2. Argentina
- 2.3. Rest of South America
-
3. Europe
- 3.1. United Kingdom
- 3.2. Germany
- 3.3. France
- 3.4. Italy
- 3.5. Spain
- 3.6. Russia
- 3.7. Benelux
- 3.8. Nordics
- 3.9. Rest of Europe
-
4. Middle East & Africa
- 4.1. Turkey
- 4.2. Israel
- 4.3. GCC
- 4.4. North Africa
- 4.5. South Africa
- 4.6. Rest of Middle East & Africa
-
5. Asia Pacific
- 5.1. China
- 5.2. India
- 5.3. Japan
- 5.4. South Korea
- 5.5. ASEAN
- 5.6. Oceania
- 5.7. Rest of Asia Pacific
Core Biopsy Devices Regional Market Share
Geographic Coverage of Core Biopsy Devices
Core Biopsy Devices REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2020-2034 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Historical Period | 2020-2025 |
| Growth Rate | CAGR of XX% from 2020-2034 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.3. Market Restrains
- 3.4. Market Trends
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Global Core Biopsy Devices Analysis, Insights and Forecast, 2020-2032
- 5.1. Market Analysis, Insights and Forecast - by Application
- 5.1.1. Hospital
- 5.1.2. Clinic
- 5.1.3. Others
- 5.2. Market Analysis, Insights and Forecast - by Types
- 5.2.1. Vacuum-assisted Biopsy Devices
- 5.2.2. Image-guided Single-cylinder Excision Alternatives
- 5.3. Market Analysis, Insights and Forecast - by Region
- 5.3.1. North America
- 5.3.2. South America
- 5.3.3. Europe
- 5.3.4. Middle East & Africa
- 5.3.5. Asia Pacific
- 5.1. Market Analysis, Insights and Forecast - by Application
- 6. North America Core Biopsy Devices Analysis, Insights and Forecast, 2020-2032
- 6.1. Market Analysis, Insights and Forecast - by Application
- 6.1.1. Hospital
- 6.1.2. Clinic
- 6.1.3. Others
- 6.2. Market Analysis, Insights and Forecast - by Types
- 6.2.1. Vacuum-assisted Biopsy Devices
- 6.2.2. Image-guided Single-cylinder Excision Alternatives
- 6.1. Market Analysis, Insights and Forecast - by Application
- 7. South America Core Biopsy Devices Analysis, Insights and Forecast, 2020-2032
- 7.1. Market Analysis, Insights and Forecast - by Application
- 7.1.1. Hospital
- 7.1.2. Clinic
- 7.1.3. Others
- 7.2. Market Analysis, Insights and Forecast - by Types
- 7.2.1. Vacuum-assisted Biopsy Devices
- 7.2.2. Image-guided Single-cylinder Excision Alternatives
- 7.1. Market Analysis, Insights and Forecast - by Application
- 8. Europe Core Biopsy Devices Analysis, Insights and Forecast, 2020-2032
- 8.1. Market Analysis, Insights and Forecast - by Application
- 8.1.1. Hospital
- 8.1.2. Clinic
- 8.1.3. Others
- 8.2. Market Analysis, Insights and Forecast - by Types
- 8.2.1. Vacuum-assisted Biopsy Devices
- 8.2.2. Image-guided Single-cylinder Excision Alternatives
- 8.1. Market Analysis, Insights and Forecast - by Application
- 9. Middle East & Africa Core Biopsy Devices Analysis, Insights and Forecast, 2020-2032
- 9.1. Market Analysis, Insights and Forecast - by Application
- 9.1.1. Hospital
- 9.1.2. Clinic
- 9.1.3. Others
- 9.2. Market Analysis, Insights and Forecast - by Types
- 9.2.1. Vacuum-assisted Biopsy Devices
- 9.2.2. Image-guided Single-cylinder Excision Alternatives
- 9.1. Market Analysis, Insights and Forecast - by Application
- 10. Asia Pacific Core Biopsy Devices Analysis, Insights and Forecast, 2020-2032
- 10.1. Market Analysis, Insights and Forecast - by Application
- 10.1.1. Hospital
- 10.1.2. Clinic
- 10.1.3. Others
- 10.2. Market Analysis, Insights and Forecast - by Types
- 10.2.1. Vacuum-assisted Biopsy Devices
- 10.2.2. Image-guided Single-cylinder Excision Alternatives
- 10.1. Market Analysis, Insights and Forecast - by Application
- 11. Competitive Analysis
- 11.1. Global Market Share Analysis 2025
- 11.2. Company Profiles
- 11.2.1 Medtronic
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Financials (Based on Availability)
- 11.2.2 BD
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Financials (Based on Availability)
- 11.2.3 INRAD
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Financials (Based on Availability)
- 11.2.4 Argon Medical Devices
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Financials (Based on Availability)
- 11.2.5 Boston Scientific
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Financials (Based on Availability)
- 11.2.1 Medtronic
List of Figures
- Figure 1: Global Core Biopsy Devices Revenue Breakdown (million, %) by Region 2025 & 2033
- Figure 2: North America Core Biopsy Devices Revenue (million), by Application 2025 & 2033
- Figure 3: North America Core Biopsy Devices Revenue Share (%), by Application 2025 & 2033
- Figure 4: North America Core Biopsy Devices Revenue (million), by Types 2025 & 2033
- Figure 5: North America Core Biopsy Devices Revenue Share (%), by Types 2025 & 2033
- Figure 6: North America Core Biopsy Devices Revenue (million), by Country 2025 & 2033
- Figure 7: North America Core Biopsy Devices Revenue Share (%), by Country 2025 & 2033
- Figure 8: South America Core Biopsy Devices Revenue (million), by Application 2025 & 2033
- Figure 9: South America Core Biopsy Devices Revenue Share (%), by Application 2025 & 2033
- Figure 10: South America Core Biopsy Devices Revenue (million), by Types 2025 & 2033
- Figure 11: South America Core Biopsy Devices Revenue Share (%), by Types 2025 & 2033
- Figure 12: South America Core Biopsy Devices Revenue (million), by Country 2025 & 2033
- Figure 13: South America Core Biopsy Devices Revenue Share (%), by Country 2025 & 2033
- Figure 14: Europe Core Biopsy Devices Revenue (million), by Application 2025 & 2033
- Figure 15: Europe Core Biopsy Devices Revenue Share (%), by Application 2025 & 2033
- Figure 16: Europe Core Biopsy Devices Revenue (million), by Types 2025 & 2033
- Figure 17: Europe Core Biopsy Devices Revenue Share (%), by Types 2025 & 2033
- Figure 18: Europe Core Biopsy Devices Revenue (million), by Country 2025 & 2033
- Figure 19: Europe Core Biopsy Devices Revenue Share (%), by Country 2025 & 2033
- Figure 20: Middle East & Africa Core Biopsy Devices Revenue (million), by Application 2025 & 2033
- Figure 21: Middle East & Africa Core Biopsy Devices Revenue Share (%), by Application 2025 & 2033
- Figure 22: Middle East & Africa Core Biopsy Devices Revenue (million), by Types 2025 & 2033
- Figure 23: Middle East & Africa Core Biopsy Devices Revenue Share (%), by Types 2025 & 2033
- Figure 24: Middle East & Africa Core Biopsy Devices Revenue (million), by Country 2025 & 2033
- Figure 25: Middle East & Africa Core Biopsy Devices Revenue Share (%), by Country 2025 & 2033
- Figure 26: Asia Pacific Core Biopsy Devices Revenue (million), by Application 2025 & 2033
- Figure 27: Asia Pacific Core Biopsy Devices Revenue Share (%), by Application 2025 & 2033
- Figure 28: Asia Pacific Core Biopsy Devices Revenue (million), by Types 2025 & 2033
- Figure 29: Asia Pacific Core Biopsy Devices Revenue Share (%), by Types 2025 & 2033
- Figure 30: Asia Pacific Core Biopsy Devices Revenue (million), by Country 2025 & 2033
- Figure 31: Asia Pacific Core Biopsy Devices Revenue Share (%), by Country 2025 & 2033
List of Tables
- Table 1: Global Core Biopsy Devices Revenue million Forecast, by Application 2020 & 2033
- Table 2: Global Core Biopsy Devices Revenue million Forecast, by Types 2020 & 2033
- Table 3: Global Core Biopsy Devices Revenue million Forecast, by Region 2020 & 2033
- Table 4: Global Core Biopsy Devices Revenue million Forecast, by Application 2020 & 2033
- Table 5: Global Core Biopsy Devices Revenue million Forecast, by Types 2020 & 2033
- Table 6: Global Core Biopsy Devices Revenue million Forecast, by Country 2020 & 2033
- Table 7: United States Core Biopsy Devices Revenue (million) Forecast, by Application 2020 & 2033
- Table 8: Canada Core Biopsy Devices Revenue (million) Forecast, by Application 2020 & 2033
- Table 9: Mexico Core Biopsy Devices Revenue (million) Forecast, by Application 2020 & 2033
- Table 10: Global Core Biopsy Devices Revenue million Forecast, by Application 2020 & 2033
- Table 11: Global Core Biopsy Devices Revenue million Forecast, by Types 2020 & 2033
- Table 12: Global Core Biopsy Devices Revenue million Forecast, by Country 2020 & 2033
- Table 13: Brazil Core Biopsy Devices Revenue (million) Forecast, by Application 2020 & 2033
- Table 14: Argentina Core Biopsy Devices Revenue (million) Forecast, by Application 2020 & 2033
- Table 15: Rest of South America Core Biopsy Devices Revenue (million) Forecast, by Application 2020 & 2033
- Table 16: Global Core Biopsy Devices Revenue million Forecast, by Application 2020 & 2033
- Table 17: Global Core Biopsy Devices Revenue million Forecast, by Types 2020 & 2033
- Table 18: Global Core Biopsy Devices Revenue million Forecast, by Country 2020 & 2033
- Table 19: United Kingdom Core Biopsy Devices Revenue (million) Forecast, by Application 2020 & 2033
- Table 20: Germany Core Biopsy Devices Revenue (million) Forecast, by Application 2020 & 2033
- Table 21: France Core Biopsy Devices Revenue (million) Forecast, by Application 2020 & 2033
- Table 22: Italy Core Biopsy Devices Revenue (million) Forecast, by Application 2020 & 2033
- Table 23: Spain Core Biopsy Devices Revenue (million) Forecast, by Application 2020 & 2033
- Table 24: Russia Core Biopsy Devices Revenue (million) Forecast, by Application 2020 & 2033
- Table 25: Benelux Core Biopsy Devices Revenue (million) Forecast, by Application 2020 & 2033
- Table 26: Nordics Core Biopsy Devices Revenue (million) Forecast, by Application 2020 & 2033
- Table 27: Rest of Europe Core Biopsy Devices Revenue (million) Forecast, by Application 2020 & 2033
- Table 28: Global Core Biopsy Devices Revenue million Forecast, by Application 2020 & 2033
- Table 29: Global Core Biopsy Devices Revenue million Forecast, by Types 2020 & 2033
- Table 30: Global Core Biopsy Devices Revenue million Forecast, by Country 2020 & 2033
- Table 31: Turkey Core Biopsy Devices Revenue (million) Forecast, by Application 2020 & 2033
- Table 32: Israel Core Biopsy Devices Revenue (million) Forecast, by Application 2020 & 2033
- Table 33: GCC Core Biopsy Devices Revenue (million) Forecast, by Application 2020 & 2033
- Table 34: North Africa Core Biopsy Devices Revenue (million) Forecast, by Application 2020 & 2033
- Table 35: South Africa Core Biopsy Devices Revenue (million) Forecast, by Application 2020 & 2033
- Table 36: Rest of Middle East & Africa Core Biopsy Devices Revenue (million) Forecast, by Application 2020 & 2033
- Table 37: Global Core Biopsy Devices Revenue million Forecast, by Application 2020 & 2033
- Table 38: Global Core Biopsy Devices Revenue million Forecast, by Types 2020 & 2033
- Table 39: Global Core Biopsy Devices Revenue million Forecast, by Country 2020 & 2033
- Table 40: China Core Biopsy Devices Revenue (million) Forecast, by Application 2020 & 2033
- Table 41: India Core Biopsy Devices Revenue (million) Forecast, by Application 2020 & 2033
- Table 42: Japan Core Biopsy Devices Revenue (million) Forecast, by Application 2020 & 2033
- Table 43: South Korea Core Biopsy Devices Revenue (million) Forecast, by Application 2020 & 2033
- Table 44: ASEAN Core Biopsy Devices Revenue (million) Forecast, by Application 2020 & 2033
- Table 45: Oceania Core Biopsy Devices Revenue (million) Forecast, by Application 2020 & 2033
- Table 46: Rest of Asia Pacific Core Biopsy Devices Revenue (million) Forecast, by Application 2020 & 2033
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Core Biopsy Devices?
The projected CAGR is approximately XX%.
2. Which companies are prominent players in the Core Biopsy Devices?
Key companies in the market include Medtronic, BD, INRAD, Argon Medical Devices, Boston Scientific.
3. What are the main segments of the Core Biopsy Devices?
The market segments include Application, Types.
4. Can you provide details about the market size?
The market size is estimated to be USD XXX million as of 2022.
5. What are some drivers contributing to market growth?
N/A
6. What are the notable trends driving market growth?
N/A
7. Are there any restraints impacting market growth?
N/A
8. Can you provide examples of recent developments in the market?
N/A
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 2900.00, USD 4350.00, and USD 5800.00 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in million.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Core Biopsy Devices," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Core Biopsy Devices report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Core Biopsy Devices?
To stay informed about further developments, trends, and reports in the Core Biopsy Devices, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence